People with migraine disease experience similar barriers to health care as patients with other conditions, but these are compounded by stigma and lack of access to modern treatments.
Migraine Foundation Aotearoa New Zealand welcomes Pharmac’s Neurological Advisory Committee recommendation that migraine-specific medications should be funded with a high priority. At its September meeting, the Committee reviewed the evidence for .
Migraine Foundation Aotearoa New Zealand has been successful in its application to the Ministry of Health to add migraine questions to the 2023/24 New Zealand Health Survey. Migraine affects an estimated 642,000 people in New Zealand of all ages and .
Migraine Foundation Aotearoa New Zealand has begun to publish results from its 2022 online survey, providing much-needed data of the lived experience of people with migraine in Aotearoa. The migraine charity has released nine key insight reports, .